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 Waist circumference (cm)  Weight (kg)  BMI  log(kg/m2) 
Average height (cm)  0.24  0.44  0.13 
Waist circumference (cm)  ‐  0.88  0.88 










height Age  ‐  < 0.0001  < 0.0001  0.21  0.0088 Age2  age  0.010  0.0013  0.0091  0.0002 Assets  age, age2  < 0.0001  < 0.0001  < 0.0001  < 0.0001 Log(income)  age, age2  < 0.0001  < 0.0001  < 0.0001  < 0.0001 Number of Pregnancies  age, age2  < 0.0001  < 0.0001  0.0002  0.016 Menopausal status  age, age2  0.0005  0.0003  0.11  0.075 PC1  age, age2, all other PCs  0.67  0.069  0.35  < 0.0001 PC2  age, age2, all other PCs  0.27  0.36  0.33  0.99 PC3  age, age2, all other PCs  0.73  0.72  0.88  0.61 PC4  age, age2, all other PCs  0.96  0.11  0.27  < 0.0001 PC5  age, age2, all other PCs  0.0092  0.012  0.36  0.37 PC6  age, age2, all other PCs  0.38  0.32  0.11  0.51 PC7  age, age2, all other PCs  0.15  0.091  0.093  0.29 PC8  age, age2, all other PCs  0.15  0.082  0.06  0.18 PC9  age, age2, all other PCs  0.64  0.82  0.52  0.33 PC10  age, age2, all other PCs  0.41  0.60  0.39  0.82 All traits are measured from the 2005 survey except average height, which is the average of the baseline measurement (during initial pregnancy) and seven post‐partum measurements.  Number of pregnancies is categorized into three groups:  0–4, 5–10, and ≥11.  Significant associations (P < 0.05) are denoted in boldface.  Age, age2, household assets, natural log‐transformed household income, number of pregnancies, menopausal status, and the first five PCs were used as covariates in tests of SNP association.  BMI, natural log‐transformed body mass index; PC, principal component of population substructure. 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Table 2.3 – Demographic and descriptive statistics of the CLHNS cohort 



























































































































































































































Haplotype  rs117016164  rs11924390  rs864265  Haplotype Frequency  N Carriers  β  SE  P H1  C  C  G  0.435  1,196  ‐  ‐  ‐ H2  C  T  G  0.421  1,166  0.017  0.012  0.15 H3  C  T  T  0.075  256  0.022  0.022  0.31 
H4  C  C  T  0.044  154  −0.237  0.029  2.9 ×  10­16 H5  T  C  G  0.010  33  −0.060  0.058  0.30 






Haplotype  rs117016164  rs11924390  rs864265  Haplotype Frequency  N Carriers  β  SE  P H1  C  C  G  0.429  1,203  ‐  ‐  ‐ H2  C  T  G  0.428  1,211  0.029  0.013  0.029 H3  C  T  T  0.066  226  0.049  0.025  0.053 
H4  C  C  T  0.047  165  −0.218  0.030  8.9 ×  10­13 H5  T  C  G  0.011  40  0.149  0.057  0.0094 









Table 3.5 – General characteristics of the CLHNS samples   CLHNS offspring  CLHNS mothers N  1,695  1,764 Female (%)  45.3  100 Adiponectin (µg/ml)  2.47 (1.94, 3.10)  2.48 (1.90, 3.32) Age (years)  21.5 ± 0.3  48.5 ± 6.1 Household income (pesos/wk)  358.6 (213.6, 572.2)  398.03 (245.0, 626.7) Household assets (0 to 11)  5.2 ± 2.0  5.2 ± 1.9 Number of previous pregnancies  ‐  6.5 ± 3.0 Post‐menopausal (%)  ‐  38.3 Body mass index (kg/m2)*  20.2 (18.7, 22.2)  24.1 (21.4, 27.0) Data are from the 2005 survey and are represented by mean ± SD, median (25th percentile, 75th percentile) or %.  
* Women who were pregnant in the survey of 2005 were excluded from analysis.
   84 





Covariate  Adjusted for  β (SE)  P Age  1  −0.018 (0.029)  0.53 Age2  2  −0.065 (0.087)  0.46 
Sex†  3  −0.162 (0.018)  < 0.0001 Assets  4  −0.003 (0.004)  0.50 Log_income  4  0.015 (0.009)  0.084 



















































































































freq.  β  SE  P  N  β  SE  P  N  β  SE  P  N 
Sex 
het. P 
All clumped WC loci achieving genome­wide significance in sex­combined and/or sex­specific meta­analyses rs7162542  15  82,305,294  ADAMTSL3  C  G  0.444  ‐0.0379  0.0034  9.75E­29  229,892  ‐0.0369  0.0043  1.17E­17 126,671 ‐0.0391 0.0048 2.86E­16  103,414  7.2E‐01 rs984222  1  119,305,366  TBX15  C  G  0.375  ‐0.0361  0.0035  1.48E­25  231,215  ‐0.0360  0.0044  3.32E­16 127,407 ‐0.0360 0.0049 2.45E­13  104,001  1.0E+00 rs4239436  18  18,985,928  CABLES1  A  G  0.210  ‐0.0405  0.0041  1.01E­22  229,607  ‐0.0364  0.0054  1.14E­11 126,423 ‐0.0450 0.0058 1.46E­14  103,377  2.5E‐01 rs979012  20  6,571,374  BMP2  T  C  0.345  0.0328  0.0036  5.43E­20  229,815  0.0337  0.0047  4.63E­13 126,538  0.0303  0.0051 2.36E­09  103,471  6.0E‐01 rs1776897  6  34,302,989  HMGA1  T  G  0.919  ‐0.0613  0.0067  5.58E­20  197,374  ‐0.0715  0.0087  1.50E­16 110,346 ‐0.0476 0.0096  7.90E‐07  87,220  4.9E­02 rs3791679  2  55,950,396  EFEMP1  A  G  0.761  0.0353  0.0039  2.06E­19  228,968  0.0210  0.0051  3.76E‐05  126,097  0.0525  0.0056 3.12E­21  103,063  9.1E­06 rs2745353  6  127,494,628  RSPO3  T  C  0.511  0.0293  0.0033  7.88E­19  231,143  0.0349  0.0044  1.28E­15 127,339  0.0220  0.0047  3.14E‐06  103,997  3.2E­02 
rs2071449  12  52,714,278  HOXC5, HOXC4, 
HOXC5 
A  C  0.369  0.0315  0.0036  2.47E­18  226,567  0.0293  0.0047  4.53E­10 123,896  0.0337  0.0050 1.65E­11  102,864  4.9E‐01 
















freq.  β  SE  P  N  β  SE  P  N  β  SE  P  N 
Sex 
het. P rs1344674  3  142,607,876  ZBTB38  A  G  0.555  ‐0.0240  0.0033  4.33E­13  231,241  ‐0.0180  0.0043  3.05E‐05  127,417 ‐0.0323 0.0047 9.50E­12  104,018  1.7E­02 rs991967  1  216,682,074  TGFB2  A  C  0.708  ‐0.0260  0.0037  1.13E­12  230,157  ‐0.0232  0.0048  1.17E‐06  126,792 ‐0.0285 0.0052 4.55E­08  103,557  4.2E‐01 rs2274432  1  182,287,568  TSEN15  A  G  0.362  0.0251  0.0036  1.75E­12  227,843  0.0267  0.0046  6.80E­09 125,694  0.0230  0.0050  4.08E‐06  102,341  5.6E‐01 rs6556301  5  176,460,183  FGFR4  T  G  0.357  0.0278  0.0039  1.82E­12  191,245  0.0218  0.0051  2.00E‐05  108,078  0.0356  0.0057 6.23E­10  83,358  5.4E‐02 rs473902  9  97,296,056  PTCH1  T  G  0.916  0.0490  0.0071  4.35E­12  204,544  0.0504  0.0093  5.35E‐08  112,714  0.0485  0.0099  8.87E‐07  92,023  8.8E‐01 rs4886782  15  72,015,863  LOXL1  A  G  0.373  ‐0.0245  0.0036  5.98E­12  228,446  ‐0.0177  0.0046  1.42E‐04  125,776 ‐0.0315 0.0050 3.22E­10  102,863  3.0E­02 rs12679556  8  72,676,782  BC048982  T  G  0.753  ‐0.0263  0.0039  1.26E­11  225,056  ‐0.0345  0.0051  1.05E­11 125,085 ‐0.0157 0.0056  5.18E‐03  100,164  8.1E­03 rs798489  7  2,768,329  GNA12  T  C  0.292  ‐0.0252  0.0037  1.28E­11  230,932  ‐0.0177  0.0048  2.60E‐04  127,232 ‐0.0355 0.0053 1.84E­11  103,893  7.9E­03 rs6772896  3  135,686,037  ANAPC13  T  C  0.685  0.0242  0.0036  1.79E­11  231,246  0.0231  0.0047  8.33E‐07  127,422  0.0247  0.0051  9.80E‐07  104,017  8.1E‐01 rs6570507  6  142,721,265  GPR126  A  G  0.286  ‐0.0245  0.0037  5.73E­11  228,993  ‐0.0233  0.0049  1.64E‐06  126,106 ‐0.0268 0.0053  4.96E‐07  103,080  6.0E‐01 rs2638953  12  28,425,682  CCDC91  C  G  0.683  0.0237  0.0036  6.53E­11  228,074  0.0207  0.0047  9.51E‐06  125,951  0.0268  0.0051  1.30E‐07  102,316  3.5E‐01 rs10516107  5  173,280,762  CPEB4  A  G  0.326  0.0232  0.0036  8.29E­11  231,310  0.0290  0.0046  3.36E­10 127,451  0.0160  0.0050  1.49E‐03  104,051  4.1E­02 rs1879529  15  87,215,299  ACAN  T  G  0.284  ‐0.0239  0.0038  2.86E­10  224,276  ‐0.0222  0.0050  7.55E‐06  124,928 ‐0.0235 0.0055  1.72E‐05  99,541  8.5E‐01 rs10041657  5  108,180,327  FER  A  G  0.222  0.0251  0.0040  2.88E­10  230,824  0.0264  0.0052  4.05E‐07  127,446  0.0238  0.0057  3.26E‐05  103,570  7.2E‐01 rs1173770  5  32,856,968  C5orf23  T  C  0.402  0.0214  0.0034  4.77E­10  231,275  0.0118  0.0044  7.16E‐03  127,421  0.0328  0.0048 9.03E­12  104,047  5.8E­04 rs3862030  10  104,317,574  SUFU  A  G  0.563  0.0206  0.0033  5.83E­10  231,146  0.0275  0.0043  1.77E­10 127,315  0.0126  0.0048  8.06E‐03  104,024  1.4E­02 rs272869  5  131,705,896  SLC22A4, 
BC043424 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 β  SE 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 β  SE  P  N 
Sex 
het. P rs6437061  2  232,893,296  DIS3L2  A  C  0.602  0.0166  0.0035  1.77E‐06  229,808  0.0079  0.0044  7.42E‐02  126,658  0.0273  0.0049 2.50E­08  103,343  1.7E­03 rs7830933  8  23,659,269  NKX3­1  A  G  0.768  0.0174  0.0039  9.01E‐06  231,029  0.0328  0.0051  1.93E­10 127,293 ‐0.0017 0.0056  7.55E‐01  103,929  1.2E­06 rs10925060  1  245,717,763  OR2W5  T  C  0.024  0.0174  0.0041  2.20E‐05  140,515  0.0021  0.0051  6.81E‐01  85,186  0.0450  0.0063 9.14E­13  55,522  1.7E­08 rs3897379  1  217,826,356  ZNT8  A  G  0.188  0.0160  0.0043  2.12E‐04  231,225  0.0314  0.0055  1.53E­08 127,406 ‐0.0018 0.0061  7.66E‐01  104,012  1.6E­05 rs10195252  2  165,221,337  COBLL1  T  C  0.592  0.0114  0.0034  9.44E‐04  229,802  0.0345  0.0044  3.74E­15 126,613 ‐0.0164 0.0048  6.71E‐04  103,381  0.0E+00 rs17472426  5  159,626,935  CCNJL  T  G  0.920  0.0144  0.0067  3.11E‐02  217,564  ‐0.0140  0.0086  1.05E‐01  119,804  0.0520  0.0095 4.34E­08  97,954  3.9E­08 





































SNP rs7684221  4  17,566,452  LCORL  A  G  0.164  ‐0.0259  0.0047  4.15E­08  230,275  0.110  ‐0.0259  0.0047  3.58E­08  0  same rs710841  4  82,368,855  PRKG2  T  C  0.251  0.0287  0.0038  8.49E­14  256,871  0.231  0.0287  0.0038  4.29E­14  0  same rs1812175  4  145,794,294  HHIP  A  G  0.165  ‐0.0330  0.0045  3.95E­13  249,713  0.182  ‐0.0330  0.0045  2.26E­13  0  same rs1173734  5  32,802,174  NPR3  T  C  0.742  ‐0.0180  0.0038  2.94E‐06  252,298  0.772  ‐0.0238  0.0039  8.71E­10  0.199  0.036 rs12656497  5  32,867,696  C5orf23  T  C  0.404  0.0218  0.0034  2.03E­10  250,633  0.427  0.0260  0.0035  6.34E­14  0  0.928 rs459193  5  55,842,508  ANKRD55  A  G  0.264  0.0247  0.0038  7.66E­11  248,801  0.251  0.0247  0.0038  8.06E­11  0  0.095 rs10041657  5  108,180,327  FER  A  G  0.222  0.0251  0.0040  2.88E­10  252,897  0.210  0.0251  0.0040  3.51E­10  0  same rs272869  5  131,705,896  SLC22A4  A  G  0.404  ‐0.0212  0.0034  6.68E­10  250,715  0.404  ‐0.0212  0.0034  4.52E­10  0  same rs4868125  5  171,214,480  FBXW11  C  G  0.399  ‐0.0215  0.0036  2.93E­09  224,570  0.417  ‐0.0219  0.0036  1.10E­09  0.024  same rs1976074  5  173,317,269  CPEB4  A  T  0.328  0.0232  0.0036  9.42E­11  244,292  0.331  0.0248  0.0036  5.97E­12  0  0.964 rs6556301  5  176,460,183  FGFR4  T  G  0.357  0.0278  0.0039  1.82E­12  199,847  0.356  0.0288  0.0039  1.66E­13  0  same rs4145878  6  26,306,025  HIST1H3D  A  T  0.500  ‐0.0234  0.0049  1.79E‐06  116,237  0.468  ‐0.0903  0.0059  3.94E­53  0.336  0.363 rs806794  6  26,308,656 HIST1H2BF  A  G  0.692  0.0298  0.0037  1.89E­15  239,146  0.683  0.0679  0.0046  6.88E­49  ‐0.227  same rs994379  6  26,413,386  CR593845  C  G  0.472  ‐0.0226  0.0041  3.54E­08  166,545  0.523  ‐0.3869  0.0109  1.67E­273  0.858  0.196 rs9358925  6  26,430,747  CR593845  C  G  0.625  0.0283  0.0043  4.66E­11  161,041  0.604  0.3890  0.0115  4.82E­252  ‐0.107  0.338 rs3799380  6  26,575,161  BTN2A1  T  C  0.816  0.0099  0.0044  2.44E‐02  240,274  0.844  0.0473  0.0054  2.73E­18  ‐0.007  0.075 rs2754603  6  27,073,118 MGC22265, 
GUSBL1 















SNP rs9400239  6  109,084,356  FOXO3A  T  C  0.315  ‐0.0190  0.0036  1.66E‐07  249,608  0.273  ‐0.0198  0.0036  4.06E­08  0  NA rs2745353  6  127,494,628  RSPO3  T  C  0.511  0.0293  0.0033  7.88E­19  256,380  0.535  0.0293  0.0033  6.84E­19  0  same rs9389986  6  142,702,807  DREG, 
GPR126 
A  T  0.285  ‐0.0245  0.0037  5.73E­11  250,006  0.288  ‐0.0245  0.0037  3.57E­11  0  1.000 rs798489  7  2,768,329  GNA12  T  C  0.292  ‐0.0252  0.0037  1.28E­11  246,328  0.289  ‐0.0252  0.0037  9.75E­12  0  same rs2214442  7  20,359,312  ITGB8  A  G  0.545  ‐0.0265  0.0045  3.89E­09  138,954  0.608  ‐0.0272  0.0045  1.49E­09  0  same rs7798002  7  25,827,105  NFE2L3  T  G  0.204  0.0327  0.0042  6.97E­15  243,653  0.185  0.0332  0.0042  2.52E­15  0.002  1.000 rs2067087  7  27,208,185  HOXA13  C  G  0.694  ‐0.0230  0.0038  2.18E­09  227,617  0.694  ‐0.0261  0.0038  7.31E­12  0.082  0.002 rs849140  7  28,150,227  JAZF1  T  C  0.404  0.0288  0.0034  4.74E­17  250,602  0.412  0.0314  0.0034  3.60E­20  0  same rs822531  7  148,260,692 NR_001571  T  C  0.782  0.0244  0.0044  3.71E­08  211,273  0.790  0.0244  0.0044  2.94E­08  0  same rs12679556  8  72,676,782  MSC  T  G  0.753  ‐0.0263  0.0039  1.26E­11  246,304  0.771  ‐0.0263  0.0039  1.55E­11  0  same rs11144688  9  77,732,106  PCSK5  A  G  0.126  ‐0.0336  0.0060  1.87E­08  176,235  0.133  ‐0.0336  0.0060  2.15E­08  0  same rs473902  9  97,296,056  PTCH1  T  G  0.916  0.0490  0.0071  4.35E­12  180,259  0.909  0.0455  0.0071  1.66E­10  0.088  same rs7854560  9  97,422,771  PTCH1  T  C  0.296  0.0259  0.0037  4.78E­12  244,525  0.297  0.0241  0.0037  8.25E­11  0  0.005 rs780159  10  80,577,153  ZMIZ1  A  G  0.416  ‐0.0212  0.0035  1.75E­09  234,387  0.419  ‐0.0212  0.0035  1.39E­09  0  same rs11191295  10  104,221,044  UNQ5807, 
TMEM180 
A  G  0.471  ‐0.0226  0.0036  5.40E­10  216,059  0.490  ‐0.0226  0.0036  3.45E­10  0  0.799 rs606452  11  74,953,826  SERPINH1  A  C  0.145  0.0276  0.0048  1.10E­08  244,560  0.152  0.0276  0.0048  8.94E­09  0  same rs2638953  12  28,425,682  CCDC91  C  G  0.683  0.0237  0.0036  6.53E­11  248,616  0.674  0.0237  0.0036  4.62E­11  0  same rs2071449  12  52,714,278  HOXC5, 
HOXC4 
















SNP rs4886648  15  73,095,890  SCAMP5  A  G  0.434  0.0169  0.0037  4.34E‐06  207,519  0.459  0.0204  0.0037  3.76E­08  0.041  NA rs2562779  15  82,181,979 ADAMTSL3  A  G  0.818  0.0461  0.0063  2.53E­13  117,998  0.974  0.0391  0.0063  6.96E­10  0  0.027 rs7162542  15  82,305,294 ADAMTSL3  C  G  0.444  ‐0.0379  0.0034  9.75E­29  244,448  0.453  ‐0.0364  0.0034  1.94E­26  ‐0.006  same rs1879529  15  87,215,299  ACAN  T  G  0.284  ‐0.0239  0.0038  2.86E­10  237,726  0.310  ‐0.0240  0.0038  2.75E­10  0  same rs4246302  15  98,505,490 ADAMTS17  A  G  0.681  ‐0.0216  0.0037  5.73E­09  234,578  0.717  ‐0.0220  0.0037  2.73E­09  0.019  same rs4567683  15  98,596,360 ADAMTS17  A  G  0.267  0.0219  0.0038  7.67E­09  246,783  0.240  0.0223  0.0038  4.27E­09  0  0.009 rs2047937  16  48,422,292  ZNF423  T  C  0.503  ‐0.0186  0.0034  4.67E­08  241,447  0.453  ‐0.0186  0.0034  4.49E­08  0  same rs16957358  16  65,952,042  LRRC36  A  G  0.957  0.0463  0.0083  2.70E­08  244,505  0.962  0.0463  0.0083  2.43E­08  0  0.654 rs3760318  17  26,271,841  CENTA2  A  G  0.376  ‐0.0213  0.0035  9.05E­10  242,869  0.336  ‐0.0213  0.0035  1.16E­09  0  same rs757608  17  56,852,059  C17orf82  A  G  0.319  0.0268  0.0036  9.98E­14  247,648  0.311  0.0268  0.0036  9.80E­14  0  same rs4239436  18  18,985,928  CABLES1  A  G  0.210  ‐0.0405  0.0041  1.01E­22  250,051  0.223  ‐0.0405  0.0041  5.28E­23  0  same rs4542783  19  8,548,160  MYO1F  T  C  0.540  0.0227  0.0040  1.69E­08  175,543  0.562  0.0229  0.0040  1.10E­08  ‐0.008  same rs12608504  19  18,250,135  JUND  A  G  0.357  0.0201  0.0036  1.48E­08  234,572  0.317  0.0202  0.0036  1.87E­08  0  same rs3786897  19  38,584,848  PEPD  A  G  0.582  ‐0.0199  0.0035  8.77E­09  234,057  0.576  ‐0.0199  0.0035  1.31E­08  0  same rs1884897  20  6,560,832  BMP2  A  G  0.360  0.0320  0.0035  6.56E­20  247,111  0.380  0.0320  0.0035  6.17E­20  0  0.852 rs2179129  22  27,780,923  bK175E3.6  A  G  0.588  0.0190  0.0034  2.64E­08  249,105  0.607  0.0190  0.0034  2.30E­08  0  0.807 
















SNP rs17451107  3  158,280,303  FLJ16641  T  C  0.612  0.0322  0.0046  3.51E­12  125,469  0.617  0.0322  0.0046  2.58E­12  0  same rs13173241  5  55,897,116  MEKK1  A  G  0.195  0.0484  0.0055  2.55E­18  132,943  0.140  0.0484  0.0055  1.40E­18  0  same rs10516107  5  173,280,762  CPEB4  A  G  0.323  0.0290  0.0046  3.36E­10  136,401  0.332  0.0290  0.0046  2.91E­10  0  same rs9378213  6  32,556,376  HLA­DRA  T  G  0.578  ‐0.0236  0.0045  1.49E‐07  127,738  0.604  ‐0.0255  0.0045  1.61E­08  ‐0.001  NA rs1776897  6  34,302,989 NR_001561  T  G  0.918  ‐0.0715  0.0087  1.50E­16  111,035  0.929  ‐0.0865  0.0091  2.93E­21  ‐0.304  same rs9470001  6  35,441,719  PPARD  C  G  0.051  ‐0.0382  0.0109  4.49E‐04  110,115  0.049  ‐0.0715  0.0115  4.62E­10  ‐0.028  NA rs998584  6  43,865,874  VEGFA  A  C  0.484  0.0564  0.0049  4.15E­30  105,085  0.460  0.0543  0.0049  1.69E­28  0  same rs2745349  6  127,461,527  RSPO3  A  C  0.705  ‐0.0417  0.0048  4.56E­18  131,669  0.706  ‐0.0417  0.0048  3.79E­18  0  0.141 rs10232819  7  25,843,137  NFE2L3  T  C  0.749  ‐0.0331  0.0050  4.11E­11  134,158  0.769  ‐0.0344  0.0050  6.57E­12  0  0.693 rs849140  7  28,150,227  JAZF1  T  C  0.404  0.0317  0.0044  5.41E­13  135,270  0.412  0.0327  0.0044  1.07E­13  0  same rs7830933  8  23,659,269  NKX3­1  A  G  0.767  0.0328  0.0051  1.93E­10  135,852  0.783  0.0328  0.0051  1.27E­10  0  same rs12679556  8  72,676,782  MSC  T  G  0.753  ‐0.0345  0.0051  1.05E­11  130,230  0.771  ‐0.0345  0.0051  1.35E­11  0  same rs7075269  10  104,355,714  SUFU  A  G  0.436  ‐0.0275  0.0043  1.93E­10  138,756  0.428  ‐0.0275  0.0043  1.61E­10  0  1.000 rs2071449  12  52,714,278  HOXC5, 
HOXC4 
A  C  0.367  0.0293  0.0047  4.53E­10  122,848  0.392  0.0293  0.0047  4.57E­10  0  same rs12317176  12  122,970,671  KIAA2017  T  C  0.661  0.0342  0.0046  1.29E­13  133,083  0.650  0.0300  0.0047  1.24E­10  0.156  same rs863750  12  123,071,397  ZNF664  T  C  0.595  0.0306  0.0044  2.52E­12  135,187  0.600  0.0262  0.0045  4.26E­09  0  0.000 rs7162542  15  82,305,294  ADAMTSL3  C  G  0.444  ‐0.0369  0.0043  1.17E­17  138,154  0.453  ‐0.0369  0.0043  9.56E­18  0  same rs757608  17  56,852,059  C17orf82  A  G  0.321  0.0265  0.0047  1.59E­08  131,071  0.311  0.0265  0.0047  1.72E­08  0  same rs7235010  18  18,978,808  CABLES1  A  G  0.789  0.0369  0.0053  4.88E­12  134,913  0.777  0.0369  0.0053  3.38E­12  0  1.000 rs1884897  20  6,560,832  BMP2  A  G  0.362  0.0349  0.0045  5.92E­15  134,905  0.380  0.0349  0.0045  8.92E­15  0  0.852 rs2294239  22  27,779,477  bK175E3.6  A  G  0.583  0.0261  0.0044  4.19E­09  134,012  0.585  0.0261  0.0044  3.01E­09  0  same 
















SNP rs984225  1  119,305,807  WARS2  A  G  0.630  0.0360  0.0049  2.25E­13  112,150  0.687  0.0350  0.0049  1.00E­12  0  1.000 rs11205277  1  148,159,496  SF3B4  A  G  0.589  ‐0.0294  0.0052  1.25E­08  95,911  0.561  ‐0.0294  0.0052  1.58E­08  0  same rs991967  1  216,682,074  TGFB2  A  C  0.706  ‐0.0285  0.0052  4.55E­08  111,886  0.707  ‐0.0289  0.0052  2.93E­08  ‐0.015  same rs2820426  1  217,727,158  ZNT8  A  G  0.380  0.0249  0.0048  2.81E‐07  115,665  0.367  0.0263  0.0048  4.74E­08  ‐0.061  0.169 rs12127195  1  219,376,040  C1orf140  A  G  0.297  0.0283  0.0051  3.36E­08  115,611  0.317  0.0307  0.0051  1.93E­09  0  same rs10925060  1  245,717,763  OR2W5  T  C  0.025  0.0450  0.0063  9.14E­13  646,827  0.015  0.0450  0.0063  9.16E­13  0  same rs12991495  2  25,340,274  DNMT3A  T  C  0.692  0.0318  0.0053  2.31E­09  104,863  0.693  0.0318  0.0053  1.99E­09  0  same rs3791679  2  55,950,396  EFEMP1  A  G  0.762  0.0525  0.0056  3.12E­21  110,283  0.776  0.0525  0.0056  7.17E­21  0  same rs1515114  2  226,806,631  IRS1  A  G  0.525  0.0247  0.0047  1.85E‐07  114,016  0.523  0.0263  0.0047  2.36E­08  0  NA rs6437061  2  232,893,296  DIS3L2  A  C  0.606  0.0273  0.0049  2.50E­08  109,521  0.644  0.0289  0.0049  4.06E­09  0  same rs6775778  3  137,209,369  PPP2R3A  A  G  0.753  0.0316  0.0055  9.64E­09  111,602  0.770  0.0317  0.0055  8.70E­09  0.001  0.686 rs1344674  3  142,607,876  ZBTB38  A  G  0.555  ‐0.0323  0.0047  9.50E­12  115,099  0.519  ‐0.0323  0.0047  6.03E­12  0  same rs12493901  3  173,404,749  FNDC3B  A  G  0.484  ‐0.0279  0.0048  5.47E­09  109,146  0.477  ‐0.0279  0.0048  6.19E­09  0  same rs2197271  4  82,379,372  PRKG2  C  G  0.751  ‐0.0394  0.0055  6.30E­13  110,893  0.771  ‐0.0394  0.0055  7.95E­13  0  0.951 rs1812175  4  145,794,294  HHIP  A  G  0.166  ‐0.0432  0.0064  1.83E­11  110,638  0.182  ‐0.0432  0.0064  1.49E­11  0  same rs1173770  5  32,856,968  C5orf23  T  C  0.402  0.0328  0.0048  9.03E­12  113,411  0.426  0.0328  0.0048  8.38E­12  0  same rs17472426  5  159,626,935  CCNJL  T  G  0.921  0.0520  0.0095  4.34E­08  95,096  0.942  0.0520  0.0095  4.43E­08  0  same rs6556301  5  176,460,183  FGFR4  T  G  0.357  0.0356  0.0057  6.23E­10  84,157  0.356  0.0356  0.0057  4.26E­10  0  same rs7773004  6  26,375,734  HIST1H3G  A  G  0.501  0.0334  0.0047  1.83E­12  113,713  0.504  0.0334  0.0047  1.20E­12  0  0.173 rs7759938  6  105,485,647  LIN28B  T  C  0.677  ‐0.0362  0.0051  1.31E­12  110,481  0.658  ‐0.0362  0.0051  1.28E­12  0  1.000 rs798497  7  2,762,483  GNA12  A  G  0.690  0.0344  0.0051  1.46E­11  112,939  0.687  0.0344  0.0051  1.54E­11  0  1.000 
rs10876528  12  52,707,743  HOXC6, HOXC5, 
HOXC4 
A  C  0.369  0.0377  0.0055  9.17E­12  89,151  0.390  0.0377  0.0055  7.24E­12  0  0.942 






















Color  Significance  Direction of effect   P < 5 × 10‐8   P < 0.0001   P < 0.01   P < 0.05 

























Waist­hip ratio rs2124969  ITGB6             rs17451107  FLJ16641             rs12608504  JUND             rs12679556  MSC             rs10516107  CPEB4             rs2294239  bK175E3.6             rs863750  ZNF664             rs2745353  RSPO3             rs2071449  HOXC5,HOXC4             rs7830933  NKX3­1             rs13173241  MEKK1             rs2047937  ZNF423             
rs4886648  SCAMP5             
rs17472426  CCNJL             
rs3799380  BTN2A1             
rs10925060  OR2W5             
rs2754603 
MGC22265, 
GUSBL1             
rs13196692  AX747641             































    Summaries  Correlations 
Trait  Value  n  Age at menarche  BMI  SES Age at menarche (years)  13.1 ± 1.0  832  ‐  ‐0.22  ‐0.28 BMI at age 8 (kg/m2)  14.7 ± 1.3  827  < 0.0001  ‐  0.06 SES at age 8   5 (3, 6)  832  < 0.0001  0.089  ‐ 
 Values are reported as mean ± standard deviation or as median (25th percentile, 75th percentile).  SES is a standardized factor score that ranges from 1.0 to 10.0.  Pearson correlations are reported in the upper triangle with their significances in the lower triangle.  BMI, body mass index; SES, socioeconomic status. 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Table 5.2 – Associations of previously reported menarche and obesity SNPs with age of menarche in the CLHNS                     Adjusted  Unadjusted 
SNP  Chr.  Position 
Locus 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